DK196389A - N-substituerede n-amino-pyrroler, deres fremstilling og anvendelse - Google Patents

N-substituerede n-amino-pyrroler, deres fremstilling og anvendelse

Info

Publication number
DK196389A
DK196389A DK196389A DK196389A DK196389A DK 196389 A DK196389 A DK 196389A DK 196389 A DK196389 A DK 196389A DK 196389 A DK196389 A DK 196389A DK 196389 A DK196389 A DK 196389A
Authority
DK
Denmark
Prior art keywords
pyrroles
amino
substituted
preparation
Prior art date
Application number
DK196389A
Other languages
Danish (da)
English (en)
Other versions
DK196389D0 (da
Inventor
Rolf Angerbauer
Walter Huebsch
Peter Fey
Hilmar Bischoff
Dieter Petzinna
Delf Schmidt
Guenter Thomas
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3813776A external-priority patent/DE3813776A1/de
Priority claimed from IT8822264A external-priority patent/IT8822264A0/it
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK196389D0 publication Critical patent/DK196389D0/da
Publication of DK196389A publication Critical patent/DK196389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DK196389A 1988-04-23 1989-04-24 N-substituerede n-amino-pyrroler, deres fremstilling og anvendelse DK196389A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3813776A DE3813776A1 (de) 1988-04-23 1988-04-23 N-substituierte n-amino-pyrrole
IT8822264A IT8822264A0 (it) 1988-10-11 1988-10-11 N ammino pirroli n sostituiti.

Publications (2)

Publication Number Publication Date
DK196389D0 DK196389D0 (da) 1989-04-24
DK196389A true DK196389A (da) 1989-10-24

Family

ID=25867331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK196389A DK196389A (da) 1988-04-23 1989-04-24 N-substituerede n-amino-pyrroler, deres fremstilling og anvendelse

Country Status (11)

Country Link
US (1) US4988711A (zh)
EP (1) EP0339342A1 (zh)
JP (1) JPH01313460A (zh)
KR (1) KR900016125A (zh)
CN (1) CN1037145A (zh)
AU (1) AU3312389A (zh)
DK (1) DK196389A (zh)
FI (1) FI891892A (zh)
IL (1) IL90042A0 (zh)
NO (1) NO891480L (zh)
PT (1) PT90342A (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2028538A1 (en) * 1989-10-27 1991-04-28 Hideaki Natsugari 4-substituted isoquinolone derivatives, their production and use
AU660132B2 (en) * 1992-12-21 1995-06-08 Bayer Aktiengesellschaft Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine
AR008789A1 (es) 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
CN100384836C (zh) * 2000-02-29 2008-04-30 三菱制药株式会社 新型环状酰胺衍生物
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070404A1 (es) * 2005-07-29 2007-05-10 Wyeth Corp Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002662A2 (en) * 1985-10-25 1987-05-07 Sandoz Ag Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals

Also Published As

Publication number Publication date
JPH01313460A (ja) 1989-12-18
CN1037145A (zh) 1989-11-15
US4988711A (en) 1991-01-29
FI891892A (fi) 1989-10-24
DK196389D0 (da) 1989-04-24
PT90342A (pt) 1989-11-10
FI891892A0 (fi) 1989-04-20
NO891480D0 (no) 1989-04-11
KR900016125A (ko) 1990-11-12
AU3312389A (en) 1989-10-26
IL90042A0 (en) 1989-12-15
NO891480L (no) 1989-10-24
EP0339342A1 (de) 1989-11-02

Similar Documents

Publication Publication Date Title
DK374389A (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK609489A (da) Imidazolderivater, deres fremstilling og anvendelse
DK595388A (da) Benzopyranderivater, deres fremstilling og anvendelse
DK388989A (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK435289A (da) Piperazindioner, deres fremstilling og anvendelse
DK193088A (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
DK170987D0 (da) N-substituerede benzamider, deres fremstilling og anvendelse
DK278188A (da) Thiazolidin-4-on-derivater, deres fremstilling og anvendelse
DK225089D0 (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
DK360189A (da) S-adenosyl-methionin-decarboxylase-inhibitorer, deres fremstilling og anvendelse
DK196389A (da) N-substituerede n-amino-pyrroler, deres fremstilling og anvendelse
DK469389A (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
DK641989A (da) Bis-arylphosphatestere, deres fremstilling og anvendelse
DK189488D0 (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
DK223288A (da) Benzensulfornamid-derivater, deres fremstilling og anvendelse
DK592389D0 (da) Penemderivater, deres fremstilling og anvendelse
DK412188A (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK613888A (da) Acyllabdan-derivater, deres fremstilling og anvendelse
DK361388A (da) Cephemderivater, deres fremstilling og anvendelse
DK455189D0 (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse
DK163589A (da) Sakyomycin e og derivater deraf, deres fremstilling og anvendelse
DK639889D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK639789D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK625988D0 (da) Imidazoquinoxalinforbindelser, deres fremstilling og anvendelse
DK297188D0 (da) Imidazoquinoxalinforbindelser, deres fremstilling og anvendelse